Picture of Calithera Biosciences logo

CALA — Calithera Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Calithera Biosciences Shares Progress In Sapanisertib And Mivavotinib Clinical Programs

July 13 (Reuters) - Calithera Biosciences Inc  CALA.O :
    * CALITHERA BIOSCIENCES SHARES PROGRESS IN SAPANISERTIB AND
MIVAVOTINIB CLINICAL PROGRAMS AT UPCOMING LUNG CANCER AND
LYMPHOMA CONFERENCES

Source text for Eikon:  ID:nGNX5SrYBb 
Further company coverage:  CALA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Calithera Biosciences

See all news